期刊文献+

结肠癌患者细胞凋亡与预后意义的初步研究 被引量:5

An initial study of apoptosis in colorectal cancer patients and its prognostic significance
下载PDF
导出
摘要 目的探讨促凋亡蛋白Bid在大肠癌、大肠腺瘤及正常肠黏膜组织的表达差异,了解其在大肠癌生物治疗中的价值。方法应用免疫组化MaxVisionTM快捷法检测正常肠黏膜18例、结肠腺瘤21例及结肠癌83例的Bid表达。结肠癌Dukes分期为A期22例、B期20例、C期20例及D期21例。表达程度采用半定量积分法。结果Bid在结肠腺瘤中阳性表达为95.2%,高于正常肠黏膜(72.2%)及结肠癌(72.3%),前者与后二者相比,差异显著(P<0.05)。结肠癌DukesD期Bid阳性表达100%与A、B期(40.9%、55.0%)相比有极显著差异(P<0.001),DukesD期且有28.6%高表达。在结肠癌的高表达DukesD级病例,虽Bid表达为强阳性但结肠癌细胞仍不受限制持续增殖。结论结肠癌的早期阶段(结肠腺瘤)中Bid阳性率高于结肠癌,说明细胞凋亡属于结肠癌变的早期现象。结肠癌细胞可能存在使抗瘤的T细胞及NK细胞发生免疫识别困难而致免疫逃逸的途经。 Objective The apoptosis of colorectal cancer (CRC) has been received much interest recently because of its positive rate was quite different and its influence on the prognosis of CRC was not well known. Methods Immunohistochemical MaxVision^TM fast method was used to detect the expressions of Bid protein in the cell of 18 cases of normal tissues, 21cases of colon adenomas and 83 cases of colon carcinoma. In 83 cases of colon carcinoma, Duckes' stage A was 22 cases, Dukes' stage B 20 cases, Duckes' stage C 20 cases, and Duckes' stage D 21 cases respectively. The semiquantitative scores method was used to observe the expression level. Results The positive rates of Bid protein in colon adenomas were 95.2% and its expressions were higher than those in normal tissues (72.2%) and CRC (72.3 % ). In the CRC group the expression of Bid in Dukes' stage D(100.0% )was significantly higher than that in Dukes'stage A(40.9% ) and B (55.0%),besides, 28.6 % of Dukes' stage D were found to be with high expression. Conclusion The positive rate and level of pro-apoptosis protein Bid in advanced CRC patients are high. The clarification of its mechanism would be of prime importance to the future biotherapy of CRC and its prognosis.
出处 《胃肠病学和肝病学杂志》 CAS 2006年第4期376-378,共3页 Chinese Journal of Gastroenterology and Hepatology
基金 江苏省连云港市科技发展项目资助(SH0210)
关键词 大肠癌 促凋亡蛋白Bid 免疫组化 Colorectal carcinoma(CRC) Pro-apoptosis protein Bid Immunohistochemistry
  • 相关文献

参考文献7

  • 1来茂德.大肠癌.武忠弼,杨光华主编.中华外科病理学.上卷.北京:人民卫生出版社,2002.744—756.
  • 2辛刚,刘培淑,杜鹃,毛鸿鸾.卵巢癌中COX-2与VEGF-C的表达及对微淋巴管生成的影响[J].中国肿瘤,2005,14(7):474-477. 被引量:8
  • 3陈乃玲,白玲,李琳,张昶,邓涛,陈昊.慢性肝炎肝细胞线粒体超微结构改变及与凋亡蛋白的关系[J].胃肠病学和肝病学杂志,2004,13(3):283-286. 被引量:1
  • 4Guicciardi MS, Bronk SF, Werneburg NW, et al. Bid is upstream of lysosome-mediated caspase 2 activation in tumor necrosis factor a-induced hepatocyte apoptosis. Gastroenterrology ,2005,129( 1 ) :269-284.
  • 5Kroemer G, Martin, SJ. Caspase-independent cell death. Nat Mede, 2005, 11(7) :725-729.
  • 6Bennett MW , O' Connell J, Houston A, et al . Fas ligand upregulation is an early event in colonic earcinogenesis.J Clin Pathnl,2001,54(8):598-604.
  • 7Huber V, Fais S, Iero M, et al. Human Colorectal Cancer Cells Induce T- Cell Death Through Releaseof Proapoptotic Microvesicles: Role in Immune Escape. Gastroenterology, 2005,128 (7):1796-1804.

二级参考文献24

  • 1Kubo H, Fujiwara T, Jussila L, et al. Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis[J]. Blood, 2000, 96 (2): 546-555.
  • 2Weidner N. Current pathologic methoda for measuring intratumoral microvessel density with breast carcinoma and other solid tumors [J]. Breast Cancer Res Treat,1995, 36(2):169-180.
  • 3Sang Soo Seo, Yong Sang Song, Dae-hee Kang, et al. Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer[J]. Gynecologic Oncol, 2004, 92:927-935.
  • 4Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3)and KDR (VEGFR-2) receptor tyrosine kinases[J]. EMBO J, 1996, 15(2):290-298.
  • 5Valtola R, Salven P, Heikkila P, et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer[J]. Am J Pathol, 1999, 154(5):1381-1390.
  • 6Beasley NJ, Prevo R, Banerji S, et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer[J]. Cancer Res, 2002, 62:1315-1320.
  • 7Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis[J]. Nat Med, 2001, 7(2):192-198.
  • 8Yonemura Y, Fushida S, Bando E, et al. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer[J]. Eur J Cancer, 2001, 37(7):918-923.
  • 9Su JL, Shih JY, Yen ML, et al. Cyclooxygenase-2 induces EP1-and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma[J]. Cancer Res,2004,64(2):554-564.
  • 10Hengartner MO.The biochemistry of apoptosis,Nature,2000,407( ):770-775.

共引文献8

同被引文献37

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部